Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayotunde Omoz-Oarhe, M.B.,B.S.

Concepts (87)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acquired Immunodeficiency Syndrome2202322030.590 Why?
Pregnancy Complications, Infectious2202421870.480 Why?
Isoniazid520242810.450 Why?
HIV Infections112025175330.440 Why?
Tuberculosis5202420120.380 Why?
Rifampin520223510.300 Why?
Latent Tuberculosis220222230.290 Why?
Hepatitis B Vaccines120251780.220 Why?
Antitubercular Agents5202413840.200 Why?
Abortion, Spontaneous220245360.200 Why?
Tuberculosis, Pulmonary220228380.190 Why?
Alphapapillomavirus120222190.170 Why?
Adjuvants, Immunologic120259950.160 Why?
Hepatitis B120257070.160 Why?
Contraceptive Agents, Female120201230.160 Why?
Uterine Cervical Dysplasia120223920.150 Why?
Anti-HIV Agents3202445590.150 Why?
Benzoxazines320243200.140 Why?
Anti-Retroviral Agents2202317870.140 Why?
Pregnancy Outcome2202429660.130 Why?
AIDS-Related Opportunistic Infections120196640.120 Why?
Premature Birth2202418290.120 Why?
Alkynes220243260.100 Why?
Cyclopropanes220244370.100 Why?
HIV3202415850.090 Why?
Nevirapine220222730.090 Why?
Papillomavirus Infections1202216400.090 Why?
Medroxyprogesterone Acetate220221530.090 Why?
Uterine Cervical Neoplasms1202220470.090 Why?
Pregnancy42024302600.080 Why?
Incidence12023214800.060 Why?
Alum Compounds12025350.060 Why?
Aluminum Hydroxide12025550.060 Why?
Hepatitis B Antibodies120251560.060 Why?
Guanine120252820.050 Why?
Immunization Schedule120252280.050 Why?
Adult920252230440.050 Why?
Mass Screening2202254460.050 Why?
Young Adult32024598890.050 Why?
Oxazines120243580.050 Why?
Heterocyclic Compounds, 3-Ring120242950.050 Why?
Stillbirth120243810.050 Why?
Adolescent32023888350.040 Why?
Female1020253961120.040 Why?
CD4 Lymphocyte Count2201925870.040 Why?
Vaginal Smears120225130.040 Why?
Pregnancy Trimester, First120249190.040 Why?
Pyridones120248160.040 Why?
Africa120207250.040 Why?
Pharmacogenetics120226820.040 Why?
Drug Interactions1202214170.030 Why?
Humans1220257659680.030 Why?
Reference Standards1202010130.030 Why?
Delayed-Action Preparations120209670.030 Why?
Papillomaviridae1202211410.030 Why?
Middle Aged320252230090.030 Why?
Infant, Newborn22024263460.030 Why?
Piperazines1202425490.030 Why?
Sweating120131550.020 Why?
Bacteriological Techniques120132760.020 Why?
Prevalence22022158420.020 Why?
Drug Administration Schedule1201948500.020 Why?
Sputum120135130.020 Why?
Africa South of the Sahara120137510.020 Why?
Peru120138870.020 Why?
Cough120135970.020 Why?
Drug Therapy, Combination1201963090.020 Why?
Brazil1201312480.020 Why?
Standard of Care120135670.020 Why?
Early Detection of Cancer1202232360.020 Why?
Clinical Protocols1201314410.020 Why?
Medication Adherence1201921920.020 Why?
Cross-Sectional Studies22022263180.020 Why?
Radiography, Thoracic1201313150.020 Why?
India1201323340.020 Why?
Microscopy, Fluorescence1201326270.020 Why?
Fever1201316030.020 Why?
Mycobacterium tuberculosis1201319170.010 Why?
Infant12024363860.010 Why?
Male420253636980.010 Why?
Weight Loss1201327100.010 Why?
Child, Preschool12022425000.010 Why?
Predictive Value of Tests12013153980.010 Why?
Child12022805640.010 Why?
Algorithms12013140710.010 Why?
Prospective Studies12013548020.000 Why?
Aged120211711170.000 Why?
Omoz-Oarhe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.